Bidirectional functions of arsenic as a carcinogen and an anti-cancer agent in human squamous cell carcinoma

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Thang, Nguyen Dinh ^a   Yajima, Ichiro ^b   Kumasaka, Mayuko Y ^b   Kato, Masashi ^b  

^a VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; ARSENIC; CYCLIN DEPENDENT KINASE INHIBITOR 1; DRINKING WATER; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; PROTEIN MT 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CADHERIN; CARCINOGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BANGLADESH; BIOLOGICAL ACTIVITY; CELL INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR PROMOTION; UPREGULATION; WATER POLLUTION; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; TOXICITY; TUMOR CELL LINE; TUMOR INVASION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENIC; CADHERINS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITORS; NEOPLASM INVASIVENESS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P14ARF; UP-REGULATION;

EID: 84901195885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096945     Document Type: Article

References (43)

1. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, et al. (2000) Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 108: 393-397. (Pubitemid 30421015)
2. Berg M, Stengel C, Pham TK, Pham HV, Sampson ML, et al. (2007) Magnitude of arsenic pollution in the Mekong and Red River Deltas-Cambodia and Vietnam. Sci Total Environ 372: 413-425. (Pubitemid 46043366)
3. Gebel TW (1999) Arsenic and drinking water contamination. Science 283: 1458-1459.
4. Li Y, Ling M, Xu Y, Wang S, Li Z, et al. (2010) The repressive effect of NF-kappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite. Toxicol Sci 116: 174-182.
5. Pi J, Diwan BA, Sun Y, Liu J, Qu W, et al. (2008) Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic Biol Med 45: 651-658
6. Liu ZM, Huang HS (2008) Arsenic trioxide phosphorylates c-Fos to transactivate p21(WAF1/CIP1) expression. Toxicol Appl Pharmacol 233: 297-307.
7. Kato M, Hossain K, Iida M, Sato H, Uemura N, et al. (2008) Arsenic enhances matrix metalloproteinase-14 expression in fibroblasts. J Toxicol Environ Health A 71: 1053-1055. (Pubitemid 352000672)
8. Lansdown AB (1995) Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit Rev Toxicol 25: 397-462.
9. Lunghi P, Costanzo A, Levrero M, Bonati A (2004) Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53 AIP1 apoptotic pathway in leukemia cells. Blood 104: 519-525. (Pubitemid 38900036)
10. Huang HS, Chang WC, Chen CJ (2002) Involvement of reactive oxygen species in arsenite-induced downregulation of phospholipid hydroperoxide glutathione peroxidase in human epidermoid carcinoma A431 cells. Free Radic Biol Med 33: 864-873. (Pubitemid 35232321)
11. Jiang XH, Wong BC, Yuen ST, Jiang SH, Cho CH, et al. (2001) Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer 91: 173-179. (Pubitemid 32041736)
12. Huang HS, Liu ZM, Cheng YL (2011) Involvement of glycogen synthase kinase-3β in arsenic trioxide-induced p21 expression. Toxicol Sci 121: 101-109.
13. Kim YJ, Chung JY, Lee SG, Kim JY, Park JE, et al. (2011) Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: the potential involvement of p21 expression and p53 phosphorylation. Toxicology 285: 142-151.
14. Hassani S, Ghaffari SH, Zaker F, Mirzaee R, Mardani H, et al. (2013) Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest. Ann Hematol 92: 1207-1020.
15. Kim HG, Kim DG, Li S, Lee KY, Li X, et al. (2012) Polycomb (PcG) Proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation. J Biol Chem 287: 31920-31928.
16. Bottazzi ME, Zhu X, Bohmer RM, Assoian RK (1999) Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol 146: 1255-1264. (Pubitemid 29477693)
17. Roovers K, Assoian RK (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22: 818-826.
18. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163.
19. Torii S, Yamamoto T, Tsuchiya Y, Nishida E (2006) ERK MAP kinase in G cell cycle progression and cancer. Cancer Sci 97: 697-702. (Pubitemid 43983780)
20. Zhang M, Li J, Wang L, Tian Z, Zhang P, et al. (2013) Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma. Oncol Lett 6: 381-386.
21. Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, et al. (2013) MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. J Steroid Biochem Mol Biol 138: 427-434.
22. Ling Y, Zhang C, Shen R, Xu Y, Zhu C, et al. (2014) p14ARF repression induced by promoter methylation associated with metastasis in esophageal squamous cell carcinoma. Dis Esophagus 27: 182-187.
23. Zhang Y, Sturgis EM, Zafereo ME, Wei Q, Li G (2011) p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Cancer 117: 1227-1235.
24. Cheng TH, Hsu PK, Li AF, Hung IC, Huang MH, et al. (2009) Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 135: 1577-1582.
25. Lin TH, Kuo HC, Chou FP, Lu FJ (2008) Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 8:58. doi: 10.1186/1471-2407-8-58.
26. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, et al. (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160: 753-767. (Pubitemid 36298270)
27. Takino T, Tsuge H, Ozawa T, Sato H (2010) MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. Biochem Biophys Res Commun 396: 1042-1047.
28. Ota I, Li XY, Hu Y, Weiss SJ (2009) Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc Natl Acad Sci USA 106: 20318-20323.
29. Sabeh F, Shimizu-Hirota R, Weiss SJ (2009) Protease-dependent versus independent cancer cell invasion programs: three-dimensional amoeboid movement revisite. J Cell Biol 185: 11-19.
30. Sugiyama N, Varjosalo M, Meller P, Lohi J, Hyytiäinen M, et al. (2010) Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation. Cancer Res 70: 7851-7861.
31. Nriagu J, Lin TS, Mazumder DG, Chatterjee D (2012) E-cadherin polymorphisms and susceptibility to arsenic-related skin lesions in West Bengal, India. Sci Total Environ 420: 65-72.
32. Yu J, Qian H, Li Y, Wang Y, Zhang X, et al. (2007) Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol Oncol. 106: 400-406. (Pubitemid 47096659)
33. Aplin AE, Howe AK, Juliano RL (1999) Cell adhesion molecules, signal transduction and cell growth. Curr Option Cell Biol 11: 737-744.
34. Johnson J (1999) Cell adhesion molecules in the development and progression of malignant melanoma. Cancer and Metastasis Rev 18: 345-357
35. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cell induces cell migration, invasion and metastasis. J Cell Biol 148: 779-790
36. Derycke LDM, Bracke ME (2004) N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signaling. Int J Dev Biol 48: 463-476. (Pubitemid 39360397)
37. Liu P, Yang J, Pei J, Pei D, Wilson MJ (2010) Regulation of MT1-MMP activity by β-catenin in MDCK non-cancer and HT1080 cancer cells. J Cell Physiol 225: 810-821.
38. Ciołczyk-Wierzbicka D, Gil D, Laidler P (2012) The Inhibition of Cell Proliferation Using Silencing of N-Cadherin Gene by siRNA Process in Human Melanoma Cell Lines. Curr Med Chem 19: 145-151.
39. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644.
40. Yajima I, Uemura N, Nizam S, Md Khhalequzzaman, Thang ND, et al. (2012) Barium inhibits arsenic-mediated apoptotic cell death in human squamous cell carcinoma cells. Arch Toxicol 86: 961-973
41. Thang ND, Yajima I, Kumasaka MY, Ohnuma S, Yanagishita T, et al. (2011) Barium Promotes Anchorage-Independent Growth and Invasion of Human HaCaT Keratinocytes via Activation of c-SRC Kinase. PLoS ONE 6(10): e25636. doi:10.1371/journal.pone.0025636.
42. Thang ND, Yajima I, Nakagawa K, Tsuzuki T, Kumasaka MY, et al. (2012) A novel hairless mouse model for malignant melanoma. J Dermatol Sci 65: 207-212.
43. Chakraborti D, Rahman MM, Das B, Murrill M, Dey S, et al. (2010) Status of groundwater arsenic contamination in Bangladesh: a 14-year study report. Water Res 44: 5789-802.